In the News
Read articles that highlight the groundbreaking research and scientific discoveries being led by MSK’s extraordinary team.
Investigators Look Beyond Immune Checkpoint Inhibitors to Chase Moving Targets in Prostate Cancer
ASH Conference 2021: Follicular Lymphoma Therapeutic Updates
Important Insights for Treating Blood Disorders with Stem Cell Gene Therapy
Experts Forecast Cancer Research and Treatment Advances in 2022
DLBCL: Polatuzumab Vedotin Enhances Progression-Free Survival
Breast cancer-related musculoskeletal pain alleviated with acupuncture
Dr. Rampal on the Importance of Genomic Testing in Myelofibrosis
Dermatology & AI: The need to quantify skin tones
Tweet Chat Recap: Evolving Options for Newly Diagnosed Multiple Myeloma
Tiselizumab’s Mechanism of Action in Patients with Hepatocellular Carcinoma
ASCO CEO Dr. Clifford A. Hudis wraps up our final Morning Minute with some helpful reminders, and his wish for next year.
VISION: Implementation of Lutetium-177-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Approaches Reality
Memorial Sloan Kettering AI spinout, Quest Diagnostics partner to expedite cancer diagnoses
New pill offers hope for some people with lung cancer
Patients with cancer at higher risk for arterial thromboembolic events
Dr. Dang on Cardiac Safety With Pertuzumab/ Trastuzumab in Early-Stage HER2+ Breast Cancer
Low cardiac event rates with dual HER2 blockade in early breast cancer
Dr. Giralt on Omidubicel Vs Standard Umbilical Cord Blood Transplant in Hematologic Malignancies
5 Surprising Facts about Melanoma
Lenvatinib-pembrolizumab combination extends PFS, OS in advanced endometrial cancer
Medical organizations recommend cancer patients, survivors get COVID-19 vaccine
Altered Mental Status in Cancer Patients after COVID-19 Driven by “Cytokine Storm” in CSF
Oncologists Find Controversary With Pembrolizumab Approval in TMB-High Solid Tumors
AACR: Copanlisib + Rituximab Slows Relapsed Indolent Lymphoma